Trends in the human embryonic stem cell patent field.

The successful derivation of human embryonic stem (hES) cell lines in late 1990s marks the birth of a new era in biomedical research. In the USA, this landmark invention is protected by granted composition-of-matter patents. In addition to these patents, several others have been granted on further development of hES cell research, such as on differentiated cell types and in vitro and in vivo use aspects. In Europe, there is presently no consensus pertaining to the patentability of hES cells, and all patent applications pending at the European patent office are therefore awaiting a principal decision by the Enlarged Board of Appeal. The authors argue that it will be of importance to the stem cell industry that patents are granted on inventions downstream in the value chain, e.g on specialised cell types derived from hES cells and different drug discovery applications. Patents and patent applications on such inventions for the three germ layers ectoderm/neuro, endoderm/hepato and mesoderm/cardio have been examined. The number of patents increased in the period 2001 to 2006 for all three lineages with ectoderm/neuro as the most patent intensive field. There where 9-13 times more US patent applications filed related to the three lineages compared to in Europe.

Separation and quantification of Tl(I) and Tl(III) in fresh water samples.

The two oxidation states of thallium, Tl(I) and Tl(III), were quantified by IC-ICP-MS using complexation of Tl3+ with DTPA (penta-carboxymethyl-diethylenetriamine) and separation on a cation exchange column according to a modification of the method devised by Coetzee et al. In order to avoid successively lowered separation efficiency and loss of resolution during a run, a gradient elution was made using HCl instead of HNO3. With an ultrasonic nebuliser instead of a V-groove nebuliser the limit of detection for Tl(I) and Tl(III) could be lowered from 25 ng/L and 3.0 ng/L to 9.0 ng/L and 0.7 ng/L, respectively, which is adequate for many fresh water systems. The stability of Tl(III) in acidic solutions was found to be concentration dependent, with an initially high reduction rate of Tl(III). Exposure of the sample to light further increased the reduction rate. Addition of DTPA (0.01 mM) and acid (HNO3, 1%) to a sample with 1 mug/L Tl(III) stabilised the Tl(III) content for at least 48 h. Analysis of field samples showed that only acidification is inadequate to maintain the original distribution of Tl(I) and Tl(III). Internal calibration (standard addition) and correction of the analytical signal (205Tl) with a non-ionic internal standard (11B) yielded almost quantitative recoveries of both Tl(I) and Tl(III). A scheme for field sample preparation is proposed, including sampling, storage and pre-analysis treatment.

The effect of light and iron(II)/iron(III) on the distribution of Tl(I)/Tl(III) in fresh water systems.

The distribution of aqueous Tl(I)/Tl(III) as a function of light exposure and solution properties was studied by quantifying the oxidation states after separation with ion chromatography and on-line detection with ICP-MS. Ultraviolet irradiation of aqueous solutions containing 1 microg l(-1) Tl(III) and in equilibrium with the atmosphere increases the reduction rate. In systems with photoreduction of Fe(III)(aq) a quantitative oxidation of Tl(I)(aq) was observed, notably at low pH. The process is reversible, as indicated by formation of Tl(I) when the irradiated systems were kept in the dark. In systems with colloidal silica-stabilised ferrihydrite, UV irradiation also leads to oxidation of Tl(I)(aq), but not quantitatively. It is suggested that adsorption of thallium to the ferrihydrite determines the rate of oxidation. Detectable, but not quantitative, oxidation of Tl(I)(aq) took place when natural water samples with 1 microg l(-1) Tl(I)(aq) were exposed to either sunlight or UV-light. For these samples, the reduction was not quantitative when they were kept in the dark for 24 h. The results suggest that the light dependent iron cycle in fresh water systems strongly influences the redox state of thallium.

Clonal derivation and characterization of human embryonic stem cell lines.

Human embryonic stem cells (hESC) are isolated as clusters of cells from the inner cell mass of blastocysts and thus should formally be considered as heterogeneous cell populations. Homogenous hESC cultures can be obtained through subcloning. Here, we report the clonal derivation and characterization of two new hESC lines from the parental cell line SA002 and the previously clonally derived cell line AS034.1, respectively. The hESC line SA002 was recently reported to have an abnormal karyotype (trisomy 13), but within this population of cells we observed rare individual cells with an apparent normal karyotype. At a cloning efficiency of 5%, we established 33 subclones from SA002, out of which one had a diploid karyotype and this subline was designated SA002.5. From AS034.1 we established one reclone designated AS034.1.1 at a cloning efficiency of 0.1%. These two novel sublines express cell surface markers indicative of undifferentiated hESC (SSEA-3, SSEA-4, TRA-1-60, and TRA-1-81), Oct-4, alkaline phosphatase, and they display high telomerase activity. In addition, the cells are pluripotent and form derivatives of all three embryonic germ layers in vitro as well as in vivo. These results, together with the clonal character of SA002.5 and AS034.1.1 make these homogenous cell populations very useful for hESC based applications in drug development and toxicity testing. In addition, the combination of the parental trisomic hESC line SA002 and the diploid subclone SA002.5 provides a unique experimental system to study the molecular mechanisms underlying the pathologies associated with trisomy 13.